Given the role played by Mcl-1 in maintaining the survival of HER2 expressing cells, and in maintaining a significant pool of cancer initating cells among them, pathways that lead to the expression of the anti-apoptotic protein Mcl-1 are expected to contribute to the pathogenesis of HER2 amplified mammary tumors. This evidence concerns the gene MCL1 and cancer.